Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.
Diabetic medicine : a journal of the British Diabetic Association·2011
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.
International journal of clinical practice·2010
The past, present and future of hypertension management: a potential role for AT(1)-receptor antagonists.
Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Treatment of dyslipidaemias with fluvastatin.
British journal of clinical practice. Supplement·2009
Lipoprotein(a) as a marker for coronary heart disease.
British journal of clinical practice. Supplement·2009
Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
British journal of clinical practice. Supplement·2009
Risk factor management: the cardiologist's perspective.
British journal of clinical practice. Supplement·2009
Fluvastatin in combination with other lipid-lowering agents.
British journal of clinical practice. Supplement·2009
The patient at risk: who should we be treating?
British journal of clinical practice. Supplement·2009
Left Atrial Appendage Occlusion vs Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis.
Pacing and clinical electrophysiology : PACE·2026
Heart-to-kidney signal by extracellular vesicles promotes kidney injury in cardiorenal syndrome.
Cardiovascular research·2026
Hypertension: a missing piece in HFpEF?
Hypertension research : official journal of the Japanese Society of Hypertension·2026